Table 3:

Changes in clinical disease activity, biomarkers, and growth outcomes in overall cohort (N = 38)

	At UST induction (median) [IQR]	At last follow-up (median) [IQR]	p-value
aPCDAI	20.0 [10.0–30.0]	5.0 [0.0–15.0]	0.003
In clinical remission  (aPCDAI <10) (No, %)	7 (18.4%)	23 (60.5%)	0.0001
Albumin (g/dL)	3.8 [3.4–4.2]	4.1 [3.5–4.5]	0.001
Hematocrit (%)	37.4 [35.0–41.6]	40.8 [37.0–44.0]	0.0001
C-reactive protein (mg/L)	4.4 [0.9–12.0]	3.6 [0.8–9.0]	0.38
Body Mass Index (Z-score)	−0.2 [−0.71 to −0.31	−0.04 [−0.49 to 0.4]	0.31

Abbreviations: aPCDAI, abbreviated pediatric CD activity index; IQR, interquartile range; UST, ustekinumab